New shot aims to ease bone cancer pain in early trial
NCT ID NCT06380881
First seen Nov 18, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This early study tested an experimental drug called SHR-2017 in 25 adults with cancer that spread to their bones and caused moderate to severe pain. The main goals were to see how the drug moves through the body, check its safety, and measure if it helps reduce pain and prevent bone complications. Participants received the drug and were monitored for changes in pain scores and bone health markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH BONE METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Conditions
Explore the condition pages connected to this study.